Examining the Long-term Health and Economic Effects of Antimicrobial Resistance in the United States

Public Release Webinar: Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine

October 20, 2021

1:00 PM - 2:00 PM (ET)

Past

About

Antimicrobial medicines have driven a century of progress in health, lowering mortality from infectious disease and changing the risk calculation underlying surgery, cancer treatment, and many routine life events such as childbirth. Antimicrobial resistance threatens to undermine this progress.

The National Academies consensus committee report Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine describes the problem in the United States and globally, and sets out steps to better understand the burden of resistance, promote antimicrobial stewardship, preserve the useful life of antimicrobial medicines, and strengthen the pipeline for new medical products.

Additional Information

Is it a Closed Session event?

Not Closed

Contact

Leila Meymand

LMeymand@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Examining the Long-term Health and Economic Effects of Antimicrobial Resistance in the United States: Meeting #5

May 11 - 14, 2021

Past

Agenda

Download the Agenda

Materials

Moore

About

May 12, 2021, 12:30pm – 1:30pm ET: Open to the public

During this meeting, speakers from the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota discussed the agencies' progress on the National Action Plan for Combatting Antibiotic-Resistant Bacteria.

May 11, 12, 13, and 14, 2021: Closed deliberative sessions

The committee debriefed on the open session presentation, discussed next steps, and considered possible key problems in the field and their possible solutions. The committee discussed and deliberated on conclusions to include in the final report and the next steps for completing the report.

Additional Information

Is it a Closed Session event?

Partially Closed

The following committee members were present at the closed sessions of the event

Andy Stergachis
Aylin Sertkaya
Cesar de la Fuente
Eleftherios Mylonakis
Emmanuel Okello
Guillaume Lhermie
Guy Palmer
Iruka Okeke
Jennifer Dien Bard
Marta Gomez-Chiarri
Mary Wilson
Michael Baym
Michelle Soupir
Preeti Malani
Qijing Zhang

The following topics were discussed in the closed sessions:

The committee debriefed on the open session presentation, discussed next steps, and considered possible key problems in the field and their possible solutions. The committee discussed and deliberated on conclusions to include in the final report and the next steps for completing the report.

Date of posting of Closed Session Summary:

May 14, 2021

Contact

Leila Meymand

LMeymand@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Examining the Long-term Health and Economic Effects of Antimicrobial Resistance in the United States: Meeting #4

March 16 - 19, 2021

Past

Agenda

Download the Agenda

Materials

About

March 16, 2021, 11:00am – 12:05pm ET and March 19, 2021, 11:00am – 11:45pm ET: Open to the public

During these meetings, expert speakers discussed the Global Antibiotic Research and Development Partnership's work developing treatments for drug-resistant infections and the Centers for Medicare & Medicaid Services (CMS) reimbursement for new antibiotics. Speakers also presented on the challenges of using genomic data for surveillance and the role of next-generation sequencing and predictive modeling.

March 16, 17, 18 and 19, 2021: Closed deliberative sessions

Committee debriefed on the open session presentations, discussed next steps, and considered possible key problems in the field and their possible solutions. The committee discussed and deliberated on conclusions to include in the final report and the next steps for completing the report.

Additional Information

Is it a Closed Session event?

Partially Closed

The following committee members were present at the closed sessions of the event

Andy Stergachis
Aylin Sertkaya
Cesar de la Fuente
Eleftherios Mylonakis
Emmanuel Okello
Guillaume Lhermie
Guy Palmer
Iruka Okeke
Jennifer Dien Bard
Marta Gomez-Chiarri
Mary Wilson
Michael Baym
Michelle Soupir
Preeti Malani
Qijing Zhang

The following topics were discussed in the closed sessions:

Committee debriefed on the open session presentations, discussed next steps, and considered possible key problems in the field and their possible solutions. The committee discussed and deliberated on conclusions to include in the final report and the next steps for completing the report.

Date of posting of Closed Session Summary:

March 19, 2021

Contact

Leila Meymand

LMeymand@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Closed

Examining the Long-term Health and Economic Effects of Antimicrobial Resistance in the United States: Meeting #6

July 6 - 9, 2021

Past

About

July 6, 7, 8, and 9, 2021: Closed deliberative sessions

During these closed session meetings the committee reviewed draft report chapters and discussed the report's content.

Additional Information

Is it a Closed Session event?

Institution Closed

The following committee members were present at the closed sessions of the event

Andy Stergachis
Aylin Sertkaya
Cesar de la Fuente
Eleftherios Mylonakis
Emmanuel Okello
Guillaume Lhermie
Guy Palmer
Iruka Okeke
Jennifer Dien Bard
Marta Gomez-Chiarri
Mary Wilson
Michael Baym
Michelle Soupir
Preeti Malani
Qijing Zhang

The following topics were discussed in the closed sessions:

The committee reviewed draft report chapters and discussed the report's content.

Date of posting of Closed Session Summary:

July 09, 2021

Contact

Leila Meymand

LMeymand@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Closed

Susceptibility Test Breakpoints in Veterinary Medicine

April 14, 2021

1:00 PM - 2:00 PM (ET)

Past

About

During this closed session, representatives from the US Food and Drug Administration answered committee members' questions about antimicrobial susceptibility test breakpoints in veterinary medicine.

Additional Information

Is it a Closed Session event?

Institution Closed

The following committee members were present at the closed sessions of the event

Emmanuel Okello
Guillaume Lhermie
Guy Palmer
Marta Gomez-Chiarri
Qijing Zhang

The following topics were discussed in the closed sessions:

Representatives from the US Food and Drug Administration answered committee members' questions about antimicrobial susceptibility test breakpoints in veterinary medicine.

Date of posting of Closed Session Summary:

May 14, 2021

Contact

Leila Meymand

LMeymand@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Log In

Sign in to access your saved publications, downloads, and email preferences.

Former MyNAP users: You'll need to reset your password on your first login to MyAcademies. Click "Forgot password" below to receive a reset link via email. Having trouble? Visit our FAQ page to contact support.

Members of the National Academy of Sciences, National Academy of Engineering, or National Academy of Medicine should log in through their respective Academy portals.

Email (required)
Password (required)

Don't have an account?

Register

Email (required)
New password (required)
Retype password (required) Password must be at least 8 characters
I accept the terms of use
terms of use

Thank You

Thank you for creating a MyAcademies account!

Enjoy free access to thousands of National Academies' publications, a 10% discount off every purchase, and build your personal library.

Forgot Password

Enter the email address for your MyAcademies (formerly MyNAP) account to receive password reset instructions.

Reset Requested

We sent password reset instructions to your email . Follow the link in that email to create a new password. Didn't receive it? Check your spam folder or contact us for assistance.

Reset Password

New password (required)
Retype password (required) Password must be at least 8 characters

Reset Password

Your password has been reset.

Log In

Verify email

Verify Your Email Address

We sent a verification link to your email. Please check your inbox (and spam folder) and follow the link to verify your email address. If you did not receive the email, you can request a new verification link below

Subscribe

First Name
Last Name
Email (required)
I agree to receive emails from the National Academies (required)

We respect your privacy and will never share your information.

My Academies

Examining the Long-term Health and Economic Effects of Antimicrobial Resistance in the United States

Dropdown items

Public Release Webinar: Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine